Transcranial Laser Therapy in the Rehabilitation of Hemiplegic Patients From Ischemic Stroke

Efficacy of Transcranial Laser Therapy for Improving Upper Extremity Functional Recovery in Hemiplegic Patients From Ischemic Stroke

Status

Terminated

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01308216

Acronym

REHELA

Enrollment

Registered

2011-03-04

Start date

2010-11-30

Completion date

2011-12-31

Last updated

2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemiplegia

Keywords

Transcranial Laser Therapy, Hemiplegia, Rehabilitation, Physiotherapy, Ischemic stroke

Brief summary

The aim of this study is to determine the efficacy of transcranial laser therapy applied in automatic noncontact scanning mode for improving functional disability in patients with hemiplegia from ischemic stroke undergoing a rehabilitation program.

Detailed description

Transcranial laser therapy is applied with an InGa(Al)As diode laser.The laser in automatic scanning is applied over both cerebral hemisphere during 15 sessions. Patients simultaneously performed a program of therapeutic exercises 3 days a week. Outcome measures were the Fugl-Meyer Upper Extremity scale, which assessed upper limb motor function, and the Barthel index, which assessed general functional disability.

Interventions

PROCEDURElow level laser therapy procedure

Transcranial low level laser therapy by automatic scanning noncontact over both cerebral hemispheres.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

40 Years to 85 Years

Healthy volunteers

Inclusion criteria

1. Patients with hemiplegia secondary to cerebral stroke ischemic. 2. Requirement of shaving the scalp area. 3. Initiation of the TLT procedure begins between 70 and 100 days after stroke onset. 4. Informed written consent before enrolling in the study.

Exclusion criteria

1. Hemiplegia secondary to hemorrhagic stroke. 2. Metallic brain implants. 3. Neurodegenerative disorders. 4. Bilateral motor problems.

Design outcomes

Primary

Measure	Time frame	Description
Fugl-Meyer Scale	20 minutes	The upper extremity Fugl-Meyer subscale (0-66) considers flexor and extensor synegies as well as reflex activity and coordination and is specific for grading motor impairments.

Secondary

Measure	Time frame	Description
Barthel index	10 minutes	Barthel index (0-100) is composed of 10 items and assesses activities related to clothing,nourishment,personal hygiene and transference.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026